questionText: To ask the Secretary of State for Health and Social Care, what estimate he has made of the level of overdiagnosis arising from opportunistic PSA testing in England in the latest period for which data is available; and whether this was modelled in the comparator arm of the UK National Screening Committee’s economic analysis.
answerText: Drawing on the available peer reviewed evidence, the Sheffield Centre for Health and Related Research (SCHARR) has undertaken economic analysis on behalf of the UK National Screening Committee.In their modelling, in line with best practice and the standar...
heading: Prostate Cancer: Screening